Genetic Testing in the Diagnosis and Biology of Acute Leukemia 2017 Society for Hematopathology/European Association for Haematopathology Workshop Report

被引：19

作者：

Harris, Marian H. ^{[1
]}

Czuchlewski, David R. ^{[2
]}

Arber, Daniel A. ^{[3
]}

Czader, Magdalena ^{[4
]}

机构：

[1] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA

[2] Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA

[3] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA

[4] Indiana Univ, Dept Pathol & Lab Med, Indianapolis, IN 46204 USA

来源：

AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2019年 / 152卷 / 03期

关键词：

Hematopathology; Genetics; Molecular diagnostics; ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; MINIMAL RESIDUAL DISEASE; MASTERMIND-LIKE; MUTATIONS; IDENTIFICATION; EXPRESSION; AML; RUNX1;

D O I：

10.1093/ajcp/aqz093

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Objectives: The 2017 Workshop of the Society for Hematopathology/European Association for Haematopathology examined the role of molecular genetics in the diagnosis and biology of acute leukemia. Methods: Acute leukemias were reviewed in two sessions: "Genetic Testing in Diagnosis of Acute Leukemias" (53 cases) and "Genetics Revealing the Biology of Acute Leukemias" (41 cases). Results: Cases included acute lymphoblastic leukemia, acute myeloid leukemia, and acute leukemia of ambiguous lineage. Many cases demonstrated genetic alterations of known diagnostic, prognostic, and/or therapeutic significance, while others exhibited alterations that illuminated disease biology. The workshop highlighted the complexity of acute leukemia diagnosis and follow-up, while illustrating advantages and pitfalls of molecular genetic testing. Conclusions: Our understanding of the molecular genetics of acute leukemias continues to grow rapidly. Awareness of the potential complexity of genetic architecture and environment is critical and emphasizes the importance of integrating clinical information with morphologic, immunophenotypic, and molecular genetic evaluation.

引用

页码：322 / 346

页数：25

共 70 条

[21] Molecular Minimal Residual Disease in Acute Myeloid Leukemia [J].

Jongen-Lavrencic, M. ;

Grob, T. ;

Hanekamp, D. ;

Kavelaars, F. G. ;

al Hinai, A. ;

Zeilemaker, A. ;

Erpelinck-Verschueren, C. A. J. ;

Gradowska, P. L. ;

Meijer, R. ;

Cloos, J. ;

Biemond, B. J. ;

Graux, C. ;

Kooy, M. van Marwijk ;

Manz, M. G. ;

Pabst, T. ;

Passweg, J. R. ;

Havelange, V. ;

Ossenkoppele, G. J. ;

Sanders, M. A. ;

Schuurhuis, G. J. ;

Lowenberg, B. ;

Valk, P. J. M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13) :1189-1199

[22] Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Separated into Two Subgroups Associated with Survival by BCR-ABL Fluorescence in situ Hybridization of Segmented Cell Nuclei: Report from a Single Institution [J].

Kamoda, Yoshimasa ;

Izumi, Kiyotaka ;

Iioka, Futoshi ;

Akasaka, Takashi ;

Nakamura, Fumihiko ;

Kishimori, Chiyuki ;

Tsuda, Katsuyo ;

Fukutsuka, Katsuhiro ;

Okumura, Atsuko ;

Hayashida, Masahiko ;

Ohno, Hitoshi .

ACTA HAEMATOLOGICA, 2016, 136 (03) :157-166

[23] Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia [J].

Kang, Huining ;

Chen, I. -Ming ;

Wilson, Carla S. ;

Bedrick, Edward J. ;

Harvey, Richard C. ;

Atlas, Susan R. ;

Devidas, Meenakshi ;

Mullighan, Charles G. ;

Wang, Xuefei ;

Murphy, Maurice ;

Ar, Kerem ;

Wharton, Walker ;

Borowitz, Michael J. ;

Bowman, W. Paul ;

Bhojwani, Deepa ;

Carroll, William L. ;

Camitta, Bruce M. ;

Reaman, Gregory H. ;

Smith, Malcolm A. ;

Downing, James R. ;

Hunger, Stephen P. ;

Willman, Cheryl L. .

BLOOD, 2010, 115 (07) :1394-1405

[24] Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies [J].

Kim, Borahm ;

Lee, Hyeonah ;

Shin, Saeam ;

Lee, Seung-Tae ;

Choi, Jong Rak .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (01) :163-170

[25] High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas [J].

Koechert, K. ;

Ullrich, K. ;

Kreher, S. ;

Aster, J. C. ;

Kitagawa, M. ;

Joehrens, K. ;

Anagnostopoulos, I. ;

Jundt, F. ;

Lamprecht, B. ;

Zimber-Strobl, U. ;

Stein, H. ;

Janz, M. ;

Doerken, B. ;

Mathas, S. .

ONCOGENE, 2011, 30 (15) :1831-1840

[26] Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndrome [J].

Kurt, Habibe ;

Zheng, Lan ;

Kantarjian, Hagop M. ;

Tang, Guilin ;

Ravandi-Kashani, Farhad ;

Garcia-Manero, Guillermo ;

Gong, Zimu ;

Amin, Hesham M. ;

Konoplev, Sergej N. ;

Routbort, Mark J. ;

Han, Xin ;

Wang, Wei ;

Medeiros, L. Jeffery ;

Hu, Shimin .

MODERN PATHOLOGY, 2018, 31 (07) :1141-1154

[27] T-cell lymphoblastic leukemia with t(11;22)(q24;q12) and EWSR1 rearrangement [J].

Lanocha, Aleksandra Anna ;

Zdziarska, Barbara .

BLOOD, 2017, 129 (03) :393-393

[28] The JAK2 V617F mutation in de novo acute myelogenous leukemias [J].

Lee, JW ;

Kim, YG ;

Soung, YH ;

Han, KJ ;

Kim, SY ;

Rhim, HS ;

Min, WS ;

Nam, SW ;

Park, WS ;

Lee, JY ;

Yoo, NJ ;

Lee, SH .

ONCOGENE, 2006, 25 (09) :1434-1436

[29] BRAF mutations in acute leukemias [J].

Lee, JW ;

Soung, YH ;

Park, WS ;

Kim, SY ;

Nam, SW ;

Min, WS ;

Lee, JY ;

Yoo, NJ ;

Lee, SH .

LEUKEMIA, 2004, 18 (01) :170-172

[30] The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia [J].

Levine, RL ;

Loriaux, M ;

Huntly, BJP ;

Loh, ML ;

Beran, M ;

Stoffregen, E ;

Berger, R ;

Clark, JJ ;

Willis, SG ;

Nguyen, KT ;

Flores, NJ ;

Estey, E ;

Gattermann, N ;

Armstrong, S ;

Look, AT ;

Griffin, JD ;

Bernard, OA ;

Heinrich, MC ;

Gilliland, DG ;

Druker, B ;

Deininger, MWN .

BLOOD, 2005, 106 (10) :3377-3379

← 1 2 3 4 5 6 7 →